{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-005157","form_type":"8-K","ticker":"CING","cik":"0001862150","company_name":"Cingulate Inc.","filed_at":"2024-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.131918+00:00","generated_at":"2026-06-06T07:19:00.747277+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cingulate closes $7.5M public offering of common stock and warrants","bullets":["Gross proceeds $7.5M; net ~$6.5M after fees. Offering: 3.75M shares (or pre-funded warrants) plus Series A and B warrants.","Each unit priced at $2.00 includes one share (or pre-funded warrant at $1.9999), one Series A warrant ($2.00, 5yr), one Series B warrant ($2.00, 2yr).","Proceeds to fund R&D and commercialization of lead candidate CTx-1301 and for general corporate purposes.","H.C. Wainwright acted as placement agent; cash fee 7.8% of gross proceeds, expense allowance, and warrants for 150,000 shares at $2.50.","Company agreed to 90-day lock on new equity issuances and one-year ban on variable rate transactions."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-005157","json":"https://secwatch.observer/filing/0001493152-24-005157.json","markdown":"https://secwatch.observer/filing/0001493152-24-005157.md","text":"https://secwatch.observer/filing/0001493152-24-005157.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1862150/000149315224005157/0001493152-24-005157-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1862150/000149315224005157/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T07:19:00.747277+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"00c82d9b56d7a3e26e7caf0aa130ba99826d7be7","claim":"Cingulate Inc. entered into Purchase Agreement with investors (effective 2024-02-02).","evidence_excerpt":"On February 2, 2024, Cingulate Inc. (the \"Company\") entered into agreements, including a securities purchase agreement (the \"Purchase Agreement\"), with investors pursuant to which the Company agreed to sell, in a best efforts public offering (the \"Offering\") an aggregate of (i) 1,375,000 shares (the \"Shares\") of common stock, par value $0.0001 per share (the \"Common Stock\"), of the Company, (ii) pre-funded warrants (the \"Pre-Funded Warrants\") to purchase up to an aggregate of 2,375,000 shares of Common Stock (the \"Pre-Funded Warrant Shares\"), (iii) series A common warrants (the \"Series A Warrants\") to purchase up to an aggregate of 3,750,000 shares of Common Stock (the \"Series A Common Warrant Shares\"), and (iv) series B common warrants (the \"Series B Warrants\") to purchase up to an aggregate of 1,875,000 shares of Common Stock (the \"Series B Common Warrant Shares\").","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1862150/000149315224005157/0001493152-24-005157-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"investors"},{"label":"Effective","value":"2024-02-02"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}